Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence.
Rezo Therapeutics has raised $78.0M in total funding. The most recent round was Series A. The last funding was announced in November 2022.
Rezo Therapeutics's investors include Andreessen Horowitz, Norwest, SV Angel, Eli Lilly, Liquid 2 Ventures.
Rezo Therapeutics is headquartered in South San Francisco, United States.
Rezo Therapeutics identifies targets and therapies by combining distinct, unbiased technologies with artificial intelligence.
Rezo Therapeutics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Rezo Therapeutics — Funding & Investors." VCBacked, November 17, 2022, https://www.vcbacked.co/company/rezo-therapeutics. Accessed July 20, 2026.
VCBacked. (2022). Rezo Therapeutics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/rezo-therapeutics
{{cite web |title=Rezo Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/rezo-therapeutics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated